Five prominent European radiopharmaceutical manufacturers have announced the creation of EMMA (European Molecular Imaging Manufacturers Association), a Consortium designed to take advantage of its Members’ pooling of resources in manufacturing, marketing and distribution of Positron Emission Tomography (commonly known as “PET” scans) products.
This unique European solution will fill the short-term need of supporting new PET tracer compounds that are today in the last phases of clinical research and may soon become valuable products in the field of Oncology, Cardiology and Neurology. Thus, the resources of EMMA’s five strategically positioned private PET tracer manufacturing companies have been combined to offer a European-wide capability and strategic presence, with 16 production facilities already operating and many new projects under development.
EMMA’s members will initially include:
Advanced Accelerators Applications SA (“AAA”) – with laboratories in France, Italy, Switzerland and Spain. Biokosmos SA – Greece Erigal Ltd. – Ireland and the UK Map Medical Oy – Finland PET Net GmbH – Germany. Because of the significant positive impact that this industrial cooperation will have on the European PET market, it is foreseen that future additional partners could be invited to join. The consortium will have one of its members acting as its representative to third parties on a revolving basis. AAA has been appointed at this role for the first 3 years.
For more details and highlights please refer to the official press releases and press articles posted in the “press room” section.